GLP-1s claim the longevity stage at ARDD

Big Pharma leaders embrace GLP-1s as longevity drugs as debate grows on what this means for patients, pipelines and policy. At the twelfth Aging Research and Drug Discovery meeting (ARDD) in Copenhagen, the air was heavy with expectation; the conference has long been a forum where academia, biotech and pharma test their ideas, but this […] The post GLP-1s claim the longevity stage at ARDD appeared first on Longevity.Technology.